Catherine Leiendecker‐Foster

2.3k citations

32 papers · 1.5k indexed · 1 hit paper · h-index 17

Co-authors: John H. Eckfeldt Paul C. Adams Ronald T. Acton Gordon D. McLaren James C. Barton Victor R. Gordeuk David M. Reboussin Fitzroy W. Dawkins
Topics: Iron Metabolism and Disorders (20 papers)Hemoglobinopathies and Related Disorders (17 papers)Folate and B Vitamins Research (11 papers)
Cited by: Hematology Genetics Nutrition and Dietetics
Journals: New England Journal of Medicine JAMASHILAP Revista de lepidopterología
Partner nations: United States Canada Netherlands

In The Last Decade

Catherine Leiendecker‐Foster

32 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hemochromatosis and Iron-Overload Screening in a Racially Diverse Population

2005 547 citations Paul C. Adams, David M. Reboussin et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Catherine Leiendecker‐Foster

Since Specialization

Citations

This map shows the geographic impact of Catherine Leiendecker‐Foster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Leiendecker‐Foster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Leiendecker‐Foster more than expected).

Fields of papers citing papers by Catherine Leiendecker‐Foster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Leiendecker‐Foster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Leiendecker‐Foster. The network helps show where Catherine Leiendecker‐Foster may publish in the future.

Co-authorship network of co-authors of Catherine Leiendecker‐Foster

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Leiendecker‐Foster. A scholar is included among the top collaborators of Catherine Leiendecker‐Foster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Leiendecker‐Foster. Catherine Leiendecker‐Foster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Novel Association between Plasma Matrix Metalloproteinase-9 and Risk of Incident Atrial Fibrillation in a Case-Cohort Study: The Atherosclerosis Risk in Communities Study 2013 ·PLoS ONE ·Rachel Huxley,Faye L. Lopez,Richard F. MacLehose,John H. Eckfeldt,David Couper,Catherine Leiendecker‐Foster,Ron C. Hoogeveen,Lin Y. Chen,Elsayed Z. Soliman,Sunil Agarwal,Álvaro Alonso	39
2	Gene panels to help identify subgroups at high and low risk of coronary heart disease among those randomized to antihypertensive treatment 2012 ·Pharmacogenetics and Genomics ·Amy I. Lynch,John H. Eckfeldt,Barry R. Davis,Charles E. Ford,Eric Boerwinkle,Catherine Leiendecker‐Foster,Donna K. Arnett	14
3	Associations between Single Nucleotide Polymorphisms in Iron-Related Genes and Iron Status in Multiethnic Populations 2012 ·PLoS ONE ·Christine E. McLaren,Stela McLachlan,Chad Garner,Chris D. Vulpe,Victor R. Gordeuk,John H. Eckfeldt,Paul C. Adams,Ronald T. Acton,Joseph A. Murray,Catherine Leiendecker‐Foster,Beverly M. Snively,Lisa F. Barcellos,James D. Cook,Gordon D. McLaren	43
4	Tumor necrosis factor-alpha promoter variants and iron phenotypes in 785 Hemochromatosis and Iron Overload Screening (HEIRS) Study participants 2010 ·Blood Cells Molecules and Diseases ·Ronald T. Acton,James C. Barton,Catherine Leiendecker‐Foster,(unknown),Christine E. McLaren,John H. Eckfeldt	4
5	The effect of nine common polymorphisms in coagulation factor genes (F2, F5, F7, F12 and F13) on the effectiveness of statins: the GenHAT study 2009 ·Pharmacogenetics and Genomics ·Anke H. Maitland‐van der Zee,Bas Peters,Amy I. Lynch,Eric Boerwinkle,Donna K. Arnett,Suzanne Cheng,Barry R. Davis,Catherine Leiendecker‐Foster,Charles E. Ford,John H. Eckfeldt	14
6	HFE, SLC40A1, HAMP, HJV, TFR2, and FTL mutations detected by denaturing high‐performance liquid chromatography after iron phenotyping and HFE C282Y and H63D genotyping in 785 HEIRS Study participants 2009 ·American Journal of Hematology ·James C. Barton,(unknown),Catherine Leiendecker‐Foster,Honggui Li,Ronald T. Acton,Richard D. Press,John H. Eckfeldt	32
7	Heme carrier protein 1 (HCP1) genetic variants in the Hemochromatosis and Iron Overload Screening (HEIRS) Study participants 2009 ·Blood Cells Molecules and Diseases ·(unknown),Catherine Leiendecker‐Foster,Ronald T. Acton,James C. Barton,Christine E. McLaren,Gordon D. McLaren,(unknown),John H. Eckfeldt	4
8	Antihypertensive pharmacogenetic effect of fibrinogen-beta variant −455G>A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT study 2009 ·Pharmacogenetics and Genomics ·Amy I. Lynch,Eric Boerwinkle,Barry R. Davis,Charles E. Ford,John H. Eckfeldt,Catherine Leiendecker‐Foster,Donna K. Arnett	16
9	HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) Study 2008 ·Translational research ·James S. Pankow,Eric Boerwinkle,Paul C. Adams,Eliseo Güallar,Catherine Leiendecker‐Foster,(unknown),John H. Eckfeldt	46
10	Pharmacogenetic Association of the NPPA T2238C Genetic Variant With Cardiovascular Disease Outcomes in Patients With Hypertension 2008 ·JAMA ·Amy I. Lynch,Eric Boerwinkle,Barry R. Davis,Charles E. Ford,John H. Eckfeldt,Catherine Leiendecker‐Foster,Donna K. Arnett	74
11	Interactions between the single nucleotide polymorphisms in the homocysteine pathway (MTHFR 677C>T, MTHFR 1298 A>C, and CBSins) and the efficacy of HMG-CoA reductase inhibitors in preventing cardiovascular disease in high-risk patients of hypertension: the GenHAT study 2008 ·Pharmacogenetics and Genomics ·Anke H. Maitland‐van der Zee,Amy I. Lynch,Eric Boerwinkle,Donna K. Arnett,Barry R. Davis,Catherine Leiendecker‐Foster,Charles E. Ford,John H. Eckfeldt	28
12	HFE C282Y Homozygotes Aged 25–29 Years at HEIRS Study Initial Screening 2007 ·Genetic Testing ·James C. Barton,Ronald T. Acton,Catherine Leiendecker‐Foster,Laura Lovato,Paul C. Adams,Gordon D. McLaren,John H. Eckfeldt,Christine E. McLaren,David M. Reboussin,Victor R. Gordeuk,Mark Speechley,Jacob A. Reiss,Richard D. Press,Fitzroy W. Dawkins	6
13	Association of ferroportin Q248H polymorphism with elevated levels of serum ferritin in African Americans in the Hemochromatosis and Iron Overload Screening (HEIRS) Study 2007 ·Blood Cells Molecules and Diseases ·Charles Rivers,James C. Barton,Victor R. Gordeuk,Ronald T. Acton,Mark Speechley,Beverly M. Snively,Catherine Leiendecker‐Foster,Richard D. Press,Paul C. Adams,Gordon D. McLaren,Fitzroy W. Dawkins,Christine E. McLaren,David M. Reboussin	41
14	African Americans at Risk for Increased Iron Stores or Liver Disease 2007 ·The American Journal of Medicine ·Fitzroy W. Dawkins,Victor R. Gordeuk,Beverly M. Snively,Laura Lovato,James C. Barton,Ronald T. Acton,Gordon D. McLaren,Catherine Leiendecker‐Foster,Christine E. McLaren,Paul C. Adams,Mark Speechley,Emily Harris,Sharon Jackson,Elizabeth J. Thomson	7
15	Biological Variability of Transferrin Saturation and Unsaturated Iron-Binding Capacity 2007 ·The American Journal of Medicine ·Paul C. Adams,David M. Reboussin,Richard D. Press,James C. Barton,Ronald T. Acton,G C Moses,Catherine Leiendecker‐Foster,Gordon D. McLaren,Fitzroy W. Dawkins,Victor R. Gordeuk,Laura Lovato,John H. Eckfeldt	61
16	Liver Diseases in the Hemochromatosis and Iron Overload Screening Study 2006 ·Clinical Gastroenterology and Hepatology ·Paul C. Adams,Leah Passmore,Subrata Chakrabarti,David M. Reboussin,Ronald T. Acton,James C. Barton,Gordon D. McLaren,John H. Eckfeldt,Fitzroy W. Dawkins,Victor R. Gordeuk,Emily Harris,Catherine Leiendecker‐Foster,(unknown),Phyliss Sholinsky	43
17	Impact of hemochromatosis screening in patients with indeterminate results: The hemochromatosis and iron overload screening study 2006 ·Genetics in Medicine ·Roger T. Anderson,Lari Wenzel,Ann P. Walker,Andrea Ruggiero,Ronald T. Acton,Mark A. Hall,Diane C. Tucker,Elizabeth J. Thomson,Barbara Harrison,Edmund G. Howe,Joan Holup,Catherine Leiendecker‐Foster,(unknown),Paul C. Adams	13
18	Absence of an interaction between the angiotensin-converting enzyme insertion-deletion polymorphism and pravastatin on cardiovascular disease in high-risk hypertensive patients: The Genetics of Hypertension-Associated Treatment (GenHAT) study 2006 ·American Heart Journal ·Anke H. Maitland‐van der Zee,Eric Boerwinkle,Donna K. Arnett,Barry R. Davis,Catherine Leiendecker‐Foster,Michael B. Miller,Olaf H. Klungel,Charles E. Ford,John H. Eckfeldt	16
19	Hemochromatosis and Iron-Overload Screening in a Racially Diverse Populationbreakdown → 2005 ·New England Journal of Medicine ·Paul C. Adams,David M. Reboussin,James C. Barton,Christine E. McLaren,John H. Eckfeldt,Gordon D. McLaren,Fitzroy W. Dawkins,Ronald T. Acton,Emily Harris,Victor R. Gordeuk,Catherine Leiendecker‐Foster,Mark Speechley,Beverly Snively,Joan Holup,Elizabeth J. Thomson,Phyliss Sholinsky	547
20	Hemochromatosis and Iron Overload Screening (HEIRS) Study Design for an Evaluation of 100,000 Primary Care-Based Adults 2003 ·The American Journal of the Medical Sciences ·Christine E. McLaren,James C. Barton,Paul C. Adams,Emily Harris,Ronald T. Acton,Nancy Press,David M. Reboussin,Gordon D. McLaren,Phyliss Sholinsky,Ann P. Walker,Victor R. Gordeuk,Catherine Leiendecker‐Foster,Fitzroy W. Dawkins,John H. Eckfeldt,Beverly G. Mellen,Mark Speechley,Elizabeth J. Thomson	110

About Catherine Leiendecker‐Foster

Catherine Leiendecker‐Foster is a scholar working on Hematology, Genetics and Rheumatology, having authored 32 papers that have together received 1.5k indexed citations. Recurring topics across this work include Iron Metabolism and Disorders (20 papers), Hemoglobinopathies and Related Disorders (17 papers) and Folate and B Vitamins Research (11 papers). The work is most often cited by research in Hematology (919 citations), Genetics (746 citations) and Nutrition and Dietetics (574 citations). Catherine Leiendecker‐Foster has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include John H. Eckfeldt, Paul C. Adams, Ronald T. Acton, Gordon D. McLaren, James C. Barton, Victor R. Gordeuk, David M. Reboussin, Fitzroy W. Dawkins, Christine E. McLaren and Mark Speechley. Their work appears in journals such as New England Journal of Medicine, JAMA and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact